Total Payments
$984.43
2024 Payments
$87.70
Companies
17
Transactions
61
Medicare Patients
7,294
Medicare Billing
$344,096
Payment Breakdown by Category
Food & Beverage$984.43 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $984.43 | 61 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $252.02 | 15 | $0 (2024) |
| PFIZER INC. | $187.81 | 12 | $0 (2024) |
| Lilly USA, LLC | $123.38 | 8 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $70.46 | 4 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $45.10 | 3 | $0 (2023) |
| Almatica Pharma LLC | $44.21 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $35.70 | 3 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $31.84 | 2 | $0 (2021) |
| Collegium Pharmaceutical, Inc. | $30.93 | 2 | $0 (2021) |
| GlaxoSmithKline, LLC. | $28.65 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $87.70 | 4 | AstraZeneca Pharmaceuticals LP ($36.39) |
| 2023 | $198.52 | 11 | AstraZeneca Pharmaceuticals LP ($58.02) |
| 2022 | $127.70 | 7 | GlaxoSmithKline, LLC. ($28.65) |
| 2021 | $190.77 | 12 | AstraZeneca Pharmaceuticals LP ($62.28) |
| 2020 | $275.05 | 18 | PFIZER INC. ($106.02) |
| 2019 | $11.63 | 1 | PFIZER INC. ($11.63) |
| 2018 | $46.75 | 4 | Janssen Pharmaceuticals, Inc ($12.59) |
| 2017 | $46.31 | 4 | Janssen Pharmaceuticals, Inc ($23.11) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 2 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/20/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $15.06 | General |
| Category: Opioid Analgesic | ||||||
| 07/10/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/17/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $12.49 | General |
| Category: Cardiovascular | ||||||
| 05/04/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: Respiratory | ||||||
| 04/19/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Chronic Pain | ||||||
| 04/08/2021 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/31/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Neuroscience | ||||||
| 02/11/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: RESPIRATORY | ||||||
| 02/09/2021 | PFIZER INC. | COLOGUARD DNA CAPTURE REAGENTS (Device) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: GASTROINTESTINAL | ||||||
| 12/15/2020 | Lilly USA, LLC | REYVOW (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Neuroscience | ||||||
| 12/11/2020 | PFIZER INC. | FLECTOR (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 11/14/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/10/2020 | PFIZER INC. | FLECTOR (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 10/20/2020 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2020 | PFIZER INC. | FLECTOR (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 09/22/2020 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: Neuroscience | ||||||
| 09/18/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLUJAN | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/27/2020 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: GASTROINTESTINAL | ||||||
| 08/25/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/10/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $15.87 | General |
| Category: Opioid Analgesic | ||||||
| 07/09/2020 | Lilly USA, LLC | REYVOW (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Neuroscience | ||||||
| 06/25/2020 | PFIZER INC. | FLECTOR (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 06/18/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/08/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/04/2020 | PFIZER INC. | FLECTOR (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: INFLAMMATION;PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,048 | 2,563 | $226,365 | $90,556 |
| 2022 | 23 | 2,121 | 2,692 | $237,788 | $93,728 |
| 2021 | 21 | 1,510 | 2,037 | $194,338 | $79,157 |
| 2020 | 22 | 1,615 | 2,230 | $222,991 | $80,655 |
Total Patients
7,294
Total Services
9,522
Medicare Billing
$344,096
Procedure Codes
90
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 188 | 188 | $43,616 | $23,998 | 55.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 156 | 388 | $55,872 | $23,215 | 41.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 201 | 205 | $43,665 | $15,060 | 34.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 26 | 30 | $9,750 | $4,506 | 46.2% |
| 98925 | Osteopathic manipulative treatment, 1-2 body regions | Office | 2023 | 45 | 124 | $7,812 | $2,846 | 36.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 195 | 208 | $7,280 | $2,729 | 37.5% |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | Office | 2023 | 59 | 59 | $5,487 | $2,680 | 48.8% |
| 98926 | Osteopathic manipulative treatment, 3-4 body regions | Office | 2023 | 23 | 83 | $7,553 | $2,589 | 34.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 192 | 207 | $11,385 | $2,142 | 18.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 207 | 242 | $3,025 | $2,033 | 67.2% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 201 | 221 | $5,304 | $1,401 | 26.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $5,538 | $1,320 | 23.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 57 | 68 | $3,740 | $1,119 | 29.9% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 41 | 41 | $2,460 | $775.72 | 31.5% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 38 | 42 | $1,974 | $697.20 | 35.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 189 | 201 | $3,015 | $685.41 | 22.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 42 | 53 | $1,325 | $504.56 | 38.1% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 27 | 28 | $1,680 | $504.56 | 30.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $1,788 | $456.00 | 25.5% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 38 | 42 | $1,050 | $371.28 | 35.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 11 | 11 | $814.00 | $319.11 | 39.2% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2023 | 12 | 12 | $720.00 | $216.24 | 30.0% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 31 | 36 | $864.00 | $203.76 | 23.6% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 31 | 36 | $648.00 | $182.88 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 169 | 411 | $59,184 | $25,483 | 43.1% |
About Dr. Randolph Scott, D.O
Dr. Randolph Scott, D.O is a Family Medicine healthcare provider based in Tucson, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1811994353.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Randolph Scott, D.O has received a total of $984.43 in payments from pharmaceutical and medical device companies, with $87.70 received in 2024. These payments were reported across 61 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($984.43).
As a Medicare-enrolled provider, Scott has provided services to 7,294 Medicare beneficiaries, totaling 9,522 services with total Medicare billing of $344,096. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Tucson, AZ
- Active Since 06/30/2005
- Last Updated 04/03/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1811994353
Products in Payments
- FARXIGA (Drug) $221.30
- FLECTOR (Drug) $80.85
- JARDIANCE (Drug) $72.50
- EMGALITY (Drug) $48.53
- ELIQUIS (Drug) $45.81
- QUVIVIQ (Drug) $45.10
- LYRICA (Drug) $34.55
- STIOLTO RESPIMAT (Drug) $33.39
- XTAMPZA (Drug) $30.93
- REYVOW (Drug) $28.67
- SHINGRIX (Biological) $28.65
- LOREEV XR (Drug) $23.14
- INVOKANA (Drug) $23.11
- GRALISE (Drug) $21.07
- GATTEX (Drug) $20.74
- Cologuard Collection Kit (Device) $20.71
- NURTEC ODT (Drug) $16.10
- EVENITY (Biological) $15.59
- UBRELVY (Drug) $15.26
- BELBUCA (Drug) $15.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Tucson
Laurence Marsteller, M.d, M.D
Family Medicine — Payments: $250,058
Family Medicine $250,058
Mrs. Dena Petersen, Md, MD
Family Medicine — Payments: $199,328
Family Medicine $199,328
Mrs. Katherine Wilson, Do, DO
Family Medicine — Payments: $50,937
Family Medicine $50,937
Dr. Kevin Pounds, Md, MD
Family Medicine — Payments: $39,183
Family Medicine $39,183
Dr. Kimy Charani, D.o, D.O
Family Medicine — Payments: $26,955
Family Medicine $26,955
Michael Bischof, D.o, D.O
Family Medicine — Payments: $22,995
Family Medicine $22,995